A detailed history of Hrt Financial LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Hrt Financial LP holds 44,395 shares of NBIX stock, worth $6.01 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
44,395
Holding current value
$6.01 Million
% of portfolio
0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$114.58 - $153.15 $5.09 Million - $6.8 Million
44,395 New
44,395 $5.11 Million
Q1 2024

May 13, 2024

BUY
$130.4 - $143.74 $2.91 Million - $3.21 Million
22,347 Added 113.75%
41,993 $5.79 Million
Q4 2023

Feb 09, 2024

SELL
$106.07 - $132.76 $6.06 Million - $7.58 Million
-57,117 Reduced 74.41%
19,646 $2.59 Million
Q3 2023

Nov 13, 2023

BUY
$94.02 - $117.1 $7.22 Million - $8.99 Million
76,763 New
76,763 $8.64 Million
Q3 2022

Nov 14, 2022

SELL
$92.03 - $107.81 $2.24 Million - $2.62 Million
-24,311 Reduced 55.37%
19,599 $2.08 Million
Q2 2022

Aug 12, 2022

BUY
$75.79 - $100.07 $2.28 Million - $3.01 Million
30,061 Added 217.06%
43,910 $4.28 Million
Q1 2022

May 16, 2022

SELL
$72.45 - $94.81 $666,250 - $871,872
-9,196 Reduced 39.9%
13,849 $1.3 Million
Q4 2021

Feb 14, 2022

BUY
$79.65 - $106.22 $70,410 - $93,898
884 Added 3.99%
23,045 $1.96 Million
Q3 2021

Nov 15, 2021

BUY
$86.18 - $99.03 $1.23 Million - $1.42 Million
14,306 Added 182.13%
22,161 $2.13 Million
Q2 2021

Aug 16, 2021

BUY
$89.43 - $102.27 $702,472 - $803,330
7,855 New
7,855 $764,000
Q1 2021

May 17, 2021

SELL
$87.57 - $119.4 $302,641 - $412,646
-3,456 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$86.91 - $108.33 $300,360 - $374,388
3,456 New
3,456 $331,000
Q4 2019

Feb 14, 2020

SELL
$86.8 - $118.57 $201,549 - $275,319
-2,322 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$83.82 - $101.5 $283,814 - $343,679
-3,386 Reduced 59.32%
2,322 $209,000
Q2 2019

Aug 14, 2019

BUY
$72.24 - $91.27 $412,345 - $520,969
5,708 New
5,708 $481,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.